Defective Medical Devices

Defective medical devices can cause injury and harm to unknowing patients. Medical device users expect treatments to work effectively and safely without undue risk or harm. Independent institutions, such as the Food and Drug Administration (FDA), place medical devices through extensive testing before releasing them to the consumer market. If potential risks and side effects are found, they are documented thoroughly and the user of the medical device is informed of any potential detriment to their health.

Regardless of this testing, medical devices are sometimes found to be faulty under certain circumstances or to raise the overall chance of illness or injury. The Guidant Defibrillator is one example of a defective medical device. Once installed, some models of the defibrillator run the risk of causing serious injury to the patient at an unknown time. Dealing with the risks associated with a defective medical device can have life-altering consequences.

In the event a defective medical device causes injury or death, the manufacturers of the device may be held legally liable for marketing a dangerous product. Some legal actions associated with defective medical devices evolve into class action or mass tort suits, whereby those affected by the hazardous devices can make a personal injury claim for a predetermined amount of compensation.

If you or a loved one has suffered an injury, illness, or death due to a defective medical device, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.

Defective Medical Devices

Links on the Web

MedWatch Safety Alert RSS Feed FDA MedWatch Safety Alerts

Fri, 03 Feb 2012 17:18:00 -0500 Gris-PEG (griseofulvin ultramicrosize): Health Advisory - Risk of Product Mix-Up During packaging and labeling, tablets from one product type may have carried over into packaging of another product. Click here to read this Defective Medical Devices news article.

Fri, 03 Feb 2012 10:06:00 -0500 Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall - Visible Glass Particle Use of an inhaled product with glass particles has the potential to cause choking which could be life-threatening. Click here to read this Defective Medical Devices news article.

Wed, 01 Feb 2012 08:25:00 -0500 Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall - Possibility of Inexact Tablet Counts or Out of Sequence Tablets Oral contraceptive daily regimen may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. Click here to read this Defective Medical Devices news article.

Tue, 31 Jan 2012 13:10:00 -0500 Vitaflo USA Renastart: Recall - Possible Health Risk Due To Incorrectly Labeled Cans Consequences of using the incorrectly labeled product may result in high potassium blood levels (hyperkalemia) or high sodium levels in the blood (hypernatremia). Click here to read this Defective Medical Devices news article.

Mon, 30 Jan 2012 08:50:00 -0500 Treanda (bendamustine HCL): Recall - Particulate Matter in Vial Potential adverse events after intravenous administration of solutions containing particulates may include emboli and result in disruption of blood flow, causing tissue/organ damage. Click here to read this Defective Medical Devices news article.

Fri, 20 Jan 2012 17:30:00 -0500 Tysabri (natalizumab): Drug Safety Communication - New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML) The risks and benefits of continuing treatment with Tysabri should be carefully considered in patients who are found to be anti-JCV antibody positive and have one or more of the other known risk factors for PML. Click here to read this Defective Medical Devices news article.

Click here for archived Defective Medical Devices news.

National Institutes of Health (NIH) News Releases News Releases from the National Institutes of Health (NIH)

Fri, 03 Feb 2012 14:01 EST Gene regulator in brain's executive hub tracked across lifespan -- NIH study For the first time, scientists have tracked the activity, across the lifespan, of an environmentally responsive regulatory mechanism that turns genes on and off in the brain's executive hub. Among key findings of the study by National Institutes of Health scientists: genes implicated in schizophrenia and autism turn out to be members of a select club of genes in which regulatory activity peaks during an environmentally-sensitive critical period in development. Click here to read this Defective Medical Devices news article.

Thu, 02 Feb 2012 12:01 EST NIH study uncovers probable mechanism underlying resveratrol activity National Institutes of Health researchers and their colleagues have identified how resveratrol, a naturally occurring chemical found in red wine and other plant products, may confer its health benefits. Click here to read this Defective Medical Devices news article.

Thu, 02 Feb 2012 08:36 EST NCCAM's Advisory Council welcomes six new members The National Center for Complementary and Alternative Medicine (NCCAM) welcomes six new members to the National Advisory Council for Complementary and Alternative Medicine. The council serves as the principal advisory body to NCCAM, the lead federal agency for research on complementary medicine, and a component of the National Institutes of Health. Click here to read this Defective Medical Devices news article.

Wed, 01 Feb 2012 09:31 EST The NIH urges women to protect their heart health As part of American Heart Month, on Wednesday, Feb. 8, 2012, the National Heart, Lung, and Blood Institute's (NHLBI's) The Heart Truth campaign, with the support of the Foundation for the National Institutes of Health (FNIH), will showcase its signature event, the Red Dress Collection 2012 at Mercedes-Benz Fashion Week in New York City. Click here to read this Defective Medical Devices news article.

Tue, 31 Jan 2012 13:31 EST NIH-funded HIV clinical research sites to join pediatric tuberculosis vaccine study Several U.S. government-funded HIV/AIDS clinical research sites in Africa will join other collaborators in an ongoing clinical trial testing an investigational tuberculosis (TB) vaccine in infants at risk for TB infection. "We are pleased to be able to tap into our existing HIV/AIDS clinical research infrastructure to help test promising investigational vaccines against TB," said NIAID Director Anthony S. Fauci, M.D. The sites are funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Click here to read this Defective Medical Devices news article.

Mon, 30 Jan 2012 09:01 EST Award-winning physician appointed deputy director at NIMHD The National Institute on Minority Health and Health Disparities (NIMHD) announced today the appointment of M. Roy Wilson, M.D., M.S., an award-winning physician and academic administrator, as NIMH's Deputy Director Strategic Scientific Planning and Program Coordination. NIMHD is part of the National Institutes of Health. Click here to read this Defective Medical Devices news article.

Click here for archived Defective Medical Devices news.